Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Cancer control in primary care in Asia: Current challenges and future perspectives

Cancer control in primary care in Asia: Current challenges and future perspectives CANCER INCIDENCE AND MORTALITY IN ASIAN COUNTRIESCancer induces a substantial global burden of diseases in Asia. In Hong Kong, the most common malignancies include lung cancer (annual age‐standardised rate [ASR] of incidence: 45.3 per 100,000 persons), colorectal cancer (CRC; ASR 38.1), breast cancer (ASR 26.5), prostate cancer (ASR 21.2) and liver cancer (ASR 19.5) as of 2018, according to the WHO 2000 as the standard population (Hospital Authority, 2021). Among these top five cancers, CRC (+39.8%), breast cancer (+76.4%) and prostate cancer (+61.0%) had the most drastic increase in incidence as compared to the preceding year (Figure 1). The mortality rate was the highest for lung cancer (ASR 23.7), followed by CRC (ASR 12.0), liver cancer (ASR 10.1), breast cancer (ASR 4.8) and pancreatic cancer (ASR 3.9) (Hospital Authority, 2021). Except liver and prostate cancer, the number of new cases for the top five cancers was increasing.1FIGURENumber of new cases for the top five cancers in Hong Kong. Source: The Hospital Authority, Hong Kong Cancer registry. Available at: https://www3.ha.org.hk/cancereg/In Singapore, cancer incidence rates are observed to be rising over the past few decades with the ASR (per 100,000 persons) of overall cancer cases increasing from 188.7 between 1968 and 1972 to 228.8 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Care Wiley

Cancer control in primary care in Asia: Current challenges and future perspectives

Loading next page...
 
/lp/wiley/cancer-control-in-primary-care-in-asia-current-challenges-and-future-x04IjlRDnJ
Publisher
Wiley
Copyright
© 2022 John Wiley & Sons Ltd
ISSN
0961-5423
eISSN
1365-2354
DOI
10.1111/ecc.13580
Publisher site
See Article on Publisher Site

Abstract

CANCER INCIDENCE AND MORTALITY IN ASIAN COUNTRIESCancer induces a substantial global burden of diseases in Asia. In Hong Kong, the most common malignancies include lung cancer (annual age‐standardised rate [ASR] of incidence: 45.3 per 100,000 persons), colorectal cancer (CRC; ASR 38.1), breast cancer (ASR 26.5), prostate cancer (ASR 21.2) and liver cancer (ASR 19.5) as of 2018, according to the WHO 2000 as the standard population (Hospital Authority, 2021). Among these top five cancers, CRC (+39.8%), breast cancer (+76.4%) and prostate cancer (+61.0%) had the most drastic increase in incidence as compared to the preceding year (Figure 1). The mortality rate was the highest for lung cancer (ASR 23.7), followed by CRC (ASR 12.0), liver cancer (ASR 10.1), breast cancer (ASR 4.8) and pancreatic cancer (ASR 3.9) (Hospital Authority, 2021). Except liver and prostate cancer, the number of new cases for the top five cancers was increasing.1FIGURENumber of new cases for the top five cancers in Hong Kong. Source: The Hospital Authority, Hong Kong Cancer registry. Available at: https://www3.ha.org.hk/cancereg/In Singapore, cancer incidence rates are observed to be rising over the past few decades with the ASR (per 100,000 persons) of overall cancer cases increasing from 188.7 between 1968 and 1972 to 228.8

Journal

European Journal of Cancer CareWiley

Published: Sep 1, 2022

References